Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1976Diabetes

Hyperlipoproteinemia in Streptozotocin-treated Rats

View Full Paper
Ask AI
Bookmark
Share

Authors

HBH. Bar‐OnAlbert Einstein College of MedicinePRPaul S. RoheimPennington Biomedical Research CenterHEHoward A. EderBoston University

Discussion

Loading...

Member takes

Implication

This streptozotocin-sucrose rat model produces severe diabetic hyperlipidemia; leaves open translation to human disease mechanisms or therapies.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bar‐On et al. (1976) studied this question.

synapsesocial.com/papers/6a8828039fc8a8114e4a66afhttps://doi.org/10.2337/diab.25.6.509
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mechanisms for Development of Diabetic Hypertriglyceridemia in Streptozotocin-Treated Rats EFFECT OF DIET AND DURATION OF INSULIN DEFICIENCY1974 · 106 citations
  2. 2Effective Dose Regimen of Streptozotocin for Inducing Diabetes in a Rat Model2024 · 6 citations
  3. 3Dose dependent toxicity of streptozotocin inducing diabetic complications in male Sprague Dawley rats with metabolic biochemical histopathological effects2025 · 6 citations
  4. 4Deficiency of the Very Low-Density Lipoprotein (VLDL) Receptors in Streptozotocin-Induced Diabetic Rats: Insulin Dependency of the VLDL Receptor2005 · 31 citations
  5. 5Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin2013 · 147 citations